Research Design, Biostatistics, and Literature Evaluation
oversight, and patient safety research. Jt Comm J Qual
Patient Saf. 2008;34(6):349-353. https://doi.org/10.1016/
s1553-7250(08)34044-6
Luce JM, Cook DJ, Martin TR, et al. The ethi-
cal conduct of clinical research involving critically
ill patients in the United States and Canada: prin-
Med. 2004;170(12):1375-1384. https://doi.org/10.1164/
rccm.200406-726st
Newman JT, Smart A, Reese TR, Williams A, Moss M.
Surrogate and patient discrepancy regarding consent for
2594. https://doi.org/10.1097/ccm.0b013e318258ff19
Pronovost P, Needham D, Berenholtz S, et al. An
intervention to decrease catheter-related bloodstream
infections in the ICU. N Engl J Med. 2006;355(26):2725-
2732. https://doi.org/10.1056/nejmoa061115
Selby JV, Beal AC, Frank L. The Patient-Centered
Outcomes Research Institute (PCORI) national pri-
2012;307(15):1583-1584.
https://doi.org/10.1001/
jama.2012.500
Silbergleit R, Durkalski V, Lowenstein D, et al.
Intramuscular versus intravenous therapy for prehospital
status epilepticus. N Engl J Med. 2012;366(7):591-600.
https://doi.org/10.1056/nejmoa1107494
Silverman HJ, Luce JM, Schwartz J. Protecting sub-
jects with decisional impairment in research: the
rccm.200303-430cp
Stratton SJ. The Hennepin Ketamine Study. Prehosp
Disaster
Med.
2018;33(5):457-458.
https://doi.
org/10.1017/s1049023x18000924
Tait AR, Voepel-Lewis T. Digital multimedia: a new
464. https://doi.org/10.1001/jama.2014.17122
World Health Organization. The process of obtaining
informed consent. Accessed May 9, 2025. https://cdn.
who.int/media/docs/default-source/ethics/process-seek-
ing-if-printing.pdf?sfvrsn=3fac5edb_4
Study Design
Bailar JC 3rd. The promise and problems of meta-anal-
ysis. N Engl J Med. 1997;337(8):559-561. https://doi.
org/10.1056/nejm199708213370810
Gerhard T. Bias: considerations for research practice.
doi.org/10.2146/ajhp070369
Gershon AS, Jafarzadeh SR, Wilson KC, Walkey
AJ. Clinical knowledge from observational studies.
Everything you wanted to know but were afraid to ask.
doi.org/10.1164/rccm.201801-0118pp
Groenwold RH, Donders AR, Roes KC, Harrell FE
Jr, Moons KG. Dealing with missing outcome data in
Epidemiol. 2012;175(3):210-217. https://doi.org/10.1093/
aje/kwr302
Kaji AH, Lewis RJ. Noninferiority trials: is a new
2015;313(23):2371-2372.
https://doi.org/10.1001/
jama.2015.6645
Kanji S, Hayes M, Ling A, et al. Reporting guidelines
for clinical pharmacokinetic studies: the ClinPK state-
ment. Clin Pharmacokinet. 2015;54(7):783-795. https://
doi.org/10.1007/s40262-015-0236-8
Kaul S, Diamond GA. Good enough: a primer on
the analysis and interpretation of noninferiority tri-
org/10.7326/0003-4819-145-1-200607040-00011
Krag M, Marker S, Perner A, et al. Pantoprazole in
patients at risk for gastrointestinal bleeding in the ICU.
N Engl J Med. 2018;379(23):2199-2208. https://doi.
org/10.1056/nejmoa1714919
Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality
of reporting of noninferiority and equivalence random-
org/10.1001/jama.295.10.1147
LeLorier J, GrΓ©goire G, Benhaddad A, Lapierre J,
Derderian F. Discrepancies between meta-analyses and
subsequent large randomized, controlled trials. N Engl
J Med. 1997;337(8):536-542. https://doi.org/10.1056/
nejm199708213370806
McMahon AD. Approaches to combat with confounding
by indication in observational studies of intended drug